• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Gesynta Doses First Patient In Vipoglanstat Endometriosis Trial

    PR NEWSWIRE

    Gesynta Pharma Doses First Patient in Endometriosis Trial

    PHARMIWEB

    Gesynta Pharma receives orphan drug designation by FDA for systemic sclerosis

    PHARMAFILE

    Gesynta Pharma receives orphan drug designation by FDA for systemic sclerosis

    PHARMAFILE

    Gesynta Pharma announces development program for its drug candidate GS-248

    CISION

    Gesynta Pharma initiates Phase II study

    PRESS RELEASE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.